AMRN Live signals | Maximize Profits with Getagraph.com

SELL 102350 min ago

@ $1.160

Issued: 14 Feb 2024 @ 13:12

Return: -25.85%

Previous signal: Feb 13 - 10:19

Previous signal: Buy

Return: -0.85 %

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 16:00):

Stats
Today's Volume	709 669
Average Volume	1.65M
Market Cap	351.63M
EPS	$0 ( 2024-02-29 )
Next earnings date	( $-0.0400 ) 2024-05-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-5.73
ATR14	$0.00200 (0.22%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-18	Cohen Paul	Buy	179 795	Stock Option (right to buy)
2024-04-18	Cohen Paul	Buy	50 287	Restricted Stock Unit
2024-04-18	Sullivan Diane E.	Buy	179 795	Stock Option (right to buy)
2024-04-18	Sullivan Diane E.	Buy	50 287	Restricted Stock Unit
2024-04-18	Sterling Louis Iii	Buy	179 795	Stock Option (right to buy)

INSIDER POWER
88.59
Last 98 transactions
Buy: 13 429 087 \| Sell: 697 874

Volume Correlation

Long: -0.02 (neutral)

Short: -0.24 (neutral)

Signal:(80.564) Neutral

Amarin Corporation PLC Correlation

10 Most Positive Correlations
ASTR	0.96
VCNX	0.958
RSLS	0.956
MNRO	0.955
CAMP	0.954
RENT	0.954
RICK	0.953
LYT	0.953
AEMD	0.952
ENTA	0.951

10 Most Negative Correlations
PRSR	-0.961
HERA	-0.956
AGGR	-0.954
GXII	-0.952
MCAA	-0.952
CRZN	-0.949
LVRA	-0.949
LEGA	-0.949
TBSA	-0.948
XFIN	-0.947

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Amarin Corporation PLC Correlation - Currency/Commodity

0.00
( neutral )

-0.49
( neutral )

0.00
( neutral )

-0.59
( weak negative )

Amarin Corporation PLC Financials

Annual	2023
Revenue:	$308.10M
Gross Profit:	$202.59M (65.75 %)
EPS:	$-0.150

Q4	2023
Revenue:	$75.36M
Gross Profit:	$44.78M (59.41 %)
EPS:	$-0.0143

Q3	2023
Revenue:	$66.06M
Gross Profit:	$29.82M (45.15 %)
EPS:	$-0.0473

Q2	2023
Revenue:	$80.17M
Gross Profit:	$42.67M (53.22 %)
EPS:	$-0.0431

Financial Reports:

No articles found.

Amarin Corporation PLC

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.